Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Sesques

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Blood|November 9, 2016
Approach to the diagnosis and treatment of high-grade B-cell lymphomas with MYC and BCL2 and/or BCL6 rearrangementsPierre Sesques, Nathalie A Johnson
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 6, 2022
B-cell malignancies and COVID-19: a narrative reviewDavid Luque-Paz, Pierre Sesques, Florent Wallet, et al.
Expert Review of Anti-Infective Therapy|July 15, 2022
The burden of SARS-CoV-2 in patients receiving chimeric antigen receptor T cell immunotherapy: everything to loseDavid Luque-Paz, Pierre Sesques, Florent Wallet, et al.
Bulletin Du Cancer|January 29, 2019
Gilles Salles, Pierre Sesques, Emmanuelle Ferrant, et al.
Bulletin Du Cancer|December 18, 2021
CAR-T cell: Toxicities issues: Mechanisms and clinical managementFlorent Wallet, Pierre Sesques, Perrine Devic, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 2, 2025
Neutropenic events associated with new anticancer treatments, from pathophysiology to practice: a scoping review-NEW Group (Neutropenic Events Working Group)Gabriel Antherieu, Vincent Thibaud, Pierre Sesques, et al.
Cancer Cell|January 30, 2022
Immune response to three doses of mRNA SARS-CoV-2 vaccines in CD19-targeted chimeric antigen receptor T cell immunotherapy recipientsPierre Sesques, Emmanuel Bachy, Emmanuelle Ferrant, et al.
Eclinicalmedicine|October 7, 2022
Lymphomas associated with Epstein-Barr virus infection in 2020: Results from a large, unselected case series in FranceMarie Donzel, Maxime Bonjour, Jean-Damien Combes, et al.
Journal of Medical Virology|July 19, 2020
COVID-19: What type of cytokine storm are we dealing with?Guillaume Monneret, Ihsane Benlyamani, Morgane Gossez, et al.
Bulletin Du Cancer|October 12, 2023
[Antibody drug conjugates (ADC) and bispecific antibodies in oncology - report of the 2022 Saint Louis day]Florence Ranchon, Étienne Chatelut, Juliette Lambert, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Blood|November 9, 2016
Approach to the diagnosis and treatment of high-grade B-cell lymphomas with MYC and BCL2 and/or BCL6 rearrangementsPierre Sesques, Nathalie A Johnson
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 6, 2022
B-cell malignancies and COVID-19: a narrative reviewDavid Luque-Paz, Pierre Sesques, Florent Wallet, et al.
Expert Review of Anti-Infective Therapy|July 15, 2022
The burden of SARS-CoV-2 in patients receiving chimeric antigen receptor T cell immunotherapy: everything to loseDavid Luque-Paz, Pierre Sesques, Florent Wallet, et al.
Bulletin Du Cancer|January 29, 2019
Gilles Salles, Pierre Sesques, Emmanuelle Ferrant, et al.
Bulletin Du Cancer|December 18, 2021
CAR-T cell: Toxicities issues: Mechanisms and clinical managementFlorent Wallet, Pierre Sesques, Perrine Devic, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 2, 2025
Neutropenic events associated with new anticancer treatments, from pathophysiology to practice: a scoping review-NEW Group (Neutropenic Events Working Group)Gabriel Antherieu, Vincent Thibaud, Pierre Sesques, et al.
Cancer Cell|January 30, 2022
Immune response to three doses of mRNA SARS-CoV-2 vaccines in CD19-targeted chimeric antigen receptor T cell immunotherapy recipientsPierre Sesques, Emmanuel Bachy, Emmanuelle Ferrant, et al.
Eclinicalmedicine|October 7, 2022
Lymphomas associated with Epstein-Barr virus infection in 2020: Results from a large, unselected case series in FranceMarie Donzel, Maxime Bonjour, Jean-Damien Combes, et al.
Journal of Medical Virology|July 19, 2020
COVID-19: What type of cytokine storm are we dealing with?Guillaume Monneret, Ihsane Benlyamani, Morgane Gossez, et al.
Bulletin Du Cancer|October 12, 2023
[Antibody drug conjugates (ADC) and bispecific antibodies in oncology - report of the 2022 Saint Louis day]Florence Ranchon, Étienne Chatelut, Juliette Lambert, et al.
Pageof 7